Spruce Biosciences Inc SPRB:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 03/05/21 EST
18.28UNCH (UNCH)
Volume
740
Close
18.28quote price arrow up+0.14 (+0.77%)
Volume
21,189
52 week range
15.12 - 35.60

...

Loading . . .

KEY STATS

  • Open18.17
  • Day High18.52
  • Day Low17.31
  • Prev Close18.14
  • 52 Week High35.60
  • 52 Week High Date11/27/20
  • 52 Week Low15.12
  • 52 Week Low Date10/09/20
  • Market Cap425.19M
  • Shares Out23.26M
  • 10 Day Average Volume0.03M
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-0.59
  • P/E (TTM)-31.09
  • Fwd P/E (NTM)-7.36
  • EBITDA (MRQ)-17.191M
  • ROE (MRQ)-
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)6.98%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Spruce Biosciences Inc News

There is no recent news for this security.

Latest SPRB News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Spruce Biosciences, Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing therapies for endocrine disorders. The Company's development product candidate, tildacerfont, is a non-steroidal therapy that offers disease control for patients suffering from congenital adrenal hyperplasia (CAH). Tildacerfont is a non-steroidal, oral antagonist of the corticotropin-releasing hormone receptor 1 (CRF1) receptor, which is the receptor for...
Michael Grey
Chairman
Richard King
Chief Executive Officer
Chris Barnes Ph.D.
Vice President
Address
2001 Junipero Serra Blvd., Suite 640
Daly City, CA
94104-5401
United States